- Home
- SNDL vs BIOA Comparison
SNDL vs BIOA Comparison
Compare SNDL & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNDL | BIOA |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 302.7M | 255.6M |
| IPO Year | 2019 | 2024 |
Fundamental Metrics
Financial Performance| Metric | SNDL | BIOA |
|---|---|---|
| Price | $1.41 | $5.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | $3.27 | ★ $28.89 |
| AVG Volume (30 Days) | ★ 1.3M | 753.9K |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 66.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,995,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $83.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.13 | $4.81 |
| 52 Week High | $2.34 | $25.96 |
Technical Indicators
Market Signals| Indicator | SNDL | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 61.52 | 46.50 |
| Support Level | $1.34 | $4.81 |
| Resistance Level | $1.47 | $6.30 |
| Average True Range (ATR) | 0.06 | 0.45 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 87.50 | 67.39 |
Price Performance
Historical ComparisonAbout SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.